Recombinant Cynomolgus S100A9/MRP14 Protein

N-糖苷酶 F (PNGase F)酶活定义（UnitDefinition）1个酶活力单位指在10μL的反应体系中，37℃条件下1小时从10μg变性RNaseB中除去超过95%的碳水化合物所需要的酶量。储存条件-15~-25℃保存，有效期1年。使用说明变性条件下蛋白质去糖基化1）在水中加入1μLBuffer1和目标糖蛋白（1-20μg），至终体积10μL；2）100℃温度下煮沸10min使其变性，冰上冷却，离心10秒；3）加入2μL的Buffer2、2μL的10％NP-40、6μL去离子水，总反应体积20μL；4）加入0.2~0.5μL的PNGase，轻轻混匀。在37℃孵育1-3h。非变性条件下蛋白质去糖基化1）在水中加入2μL的Buffer2和目标糖蛋白（1-20μg）至体积为20μL。2）加入0.5~1μL的PNGaseF,轻轻混匀。3）37°C孵育4-24h。注意：在变性条件下大多数底物能够更好的去糖基化，在非变性条件下可能需要增加PNGaseF的量和延长孵育时间。然而，在肝脏中，IL-28A诱导的Th1细胞因子反应有助于T细胞介导的肝炎的炎症。Recombinant Cynomolgus S100A9/MRP14 Protein,His Tag

Recombinant Biotinylated Human HLA-A*03:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein,His-Avi Tag性能参数分子别名（Synonyms）MHC;KRAS;K-Ras2;KRAS2;C-K-RAS;CFC2;K-RAS2A;K-RAS2B;K-RAS4A;K-RAS4B;KRAS1;KRAS2;NS;NS3;RASK2;GTPaseKras;KI-RAS;RALD表达区间及表达系统（Source）BiotinylatedHumanHLA-A*03:01&B2M&KRASG12V(VVGAVGVGK)MonomerProteinisexpressedfromHEK293withHistagandAvitagattheC-TerminusItcontainsGly25-Thr305(HLA-A*03:01),Ile21-Met119(B2M)andVVGAVGVGKpeptide.[Accession|NP_002107.3(HLA-A*03:01)&P61769(B2M)&VVGAVGVGK]分子量大小（MolecularWeight）TheproteinhasapredictedMWof50.09kDa.Duetoglycosylation,theproteinmigratesto51-60kDabasedonSDS-PAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.纯度（Purity）>95%asdeterminedbySDS-PAGEandHPLC.制剂（Formulation）Suppliedas0.22μmfilteredsolutioninPBS(pH7.4).Recombinant Human APOE4/Apolipoprotein E Protein,HisTag泛素化反应可以修饰蛋白质，调节蛋白质降解。泛素化还影响蛋白质体事件，如蛋白质定位、活性和功能。

产品性质英文别名（EnglishSynonym）Factor-1CAS号（CASNO.）9001-32-5外观（Appearance）白色至类白色冻干粉末或块状物蛋白含量（ProteinContent）50-70%protein（(≥85%ofproteinisclottable)溶解性（Solubility）溶于0.9%生理盐水（10mg/ml），不溶于水运输和保存方法冰袋运输。-20℃保存，有效期4年。注意事项1）纤维蛋白原一般应采用37℃的生理盐水溶解，溶解时温度不宜过低，在4℃条件下以及不含盐的溶液中难以溶解。注意纤维蛋白原溶液在50℃以上变性，因此加热温度不宜超过50℃。2）为了您的安全和健康，请穿实验服并戴一次性手套操作。3）本产品作科研用途！储存液配制牛纤维蛋白原可溶于0.9%NaCl溶液，配制成2.5-10mg/ml的溶液于-20℃冻存，无菌过滤后可稳定保存约1周。注：①溶解时将本品缓慢置于37℃预热的生理盐水，可轻轻搅动使其慢慢溶解，不可旋涡震荡！②过滤时建议用0.2µm滤膜过滤，不可用0.1µm滤膜。可使用注射器缓慢过滤，不可用真空过滤。

Recombinant Biotinylated Human OX40/TNFRSF4/CD134 Protein (Primary Amine Labeling),hFc Tag性能参数分子别名（Synonyms）OX40Lreceptor;CD134;TNFRSF4;Ly-70表达区间及表达系统（Source）BiotinylatedHumanOX40/TNFRSF4/CD134Protein(PrimaryAmineLabeling)isexpressedfromHEK293withhFctagattheC-Terminus.ItcontainsLeu29-Ala216.[Accession|P43489]分子量大小（MolecularWeight）TheproteinhasapredictedMWof46.8kDa.Duetoglycosylation,theproteinmigratesto72-75kDabasedonSDS-PAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.纯度（Purity）>95%asdeterminedbySDS-PAGE制剂（Formulation）Suppliedas0.22μmfilteredsolutioninPBS(pH7.4).储存条件Theproductshouldbestoredat-85~-65℃for1yearfromdateofreceipt.Recommendtoaliquottheproteinintosmallerquantitieswhenfirstusedandavoidrepeatedfreeze-thawcycles.PreScission Protease是一种由人鼻病毒14型的3C蛋白酶（human rhinovirus）和GST组成的融合蛋白。

PE-labeled Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Tetramer Protein,His-Avi Tag性能参数表达区间及表达系统（Source）PE-labeledHumanHLA-A*02:01&B2M&P53R175H(HMTEVVRHC)TetramerProteinisexpressedfromHEK293withHistagandAvitagattheC-Terminus.PE-labeledHumanHLA-A*02:01&B2M&P53R175H(HMTEVVRHC)TetramerisassembledbybiotinylatedmonomerandPE-labeledstreptavidin.ItcontainsGly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)andHMTEVVRHCpeptide.（Endotoxin）Lessthan1EUperμgbytheLALmethod.制剂（Formulation）Suppliedas0.22μmfilteredsolutionin20mMPB,500mMNaCl,0.2%BSA(pH8.0).储存条件Theproductshouldbestoredat-85~-65℃for3monthfromdateofreceipt.Recommendtoaliquottheproteinintosmallerquantitieswhenfirstusedandavoidrepeatedfreeze-thawcycles.在体内，活化的X因子（Factor Xa）切割凝血酶原，释放出活性肽并将凝血酶切割成具有催化活性的α-凝血酶。Recombinant Cynomolgus Kremen-2 Protein,His Tag

人血清白蛋白（HSA）是脂类等物质的转运载体，其主要生理功能是调节血浆pH值和维持血浆渗透压。Recombinant Cynomolgus S100A9/MRP14 Protein,His Tag

Angiotensin I Converting Enzyme (ACE-2), also called ACEH (ACE homologue), is a dimeric, zinc-dependent metalloprotease of the ACE family that also includes somatic and germinal ACE. ACE-2 mRNA is found at high levels in heart, testis, and kidney and at lower levels in a wide variety of tissues. ACE-2 is the SARS-CoV and SARS-CoV2 Spike protein receptor in vivo, functions catalytically as a carboxypeptidase to cleave several substrates including angiotensins I and II, and acts as a partner for B0AT1-family amino acid transporters. Through these functions, ACE-2 has been shown to be involved in several diseases including SARS, COVID19, acute lung injury, heart disease, liver and lung fibrosis, inflammatory lung disease, and cardiopulmonary disease . Full length ACE-2 protein includes an extracellular region composed of a single N-terminal peptidase domain and C-terminal collectrin-like domain (CLD), a transmembrane domain, and a short cytoplasmic tail. The N-terminal peptidase region is required for binding to SARS-CoV and SARS-CoV2 spike proteins, while the CLD contains a region that promotes dimerization and association with amino acid transporters.Recombinant Cynomolgus S100A9/MRP14 Protein,His Tag